(Q51101138)

29 March 2018

title

Dimensions of quality of life expressed by men treated for metastatic prostate cancer. (English)

1 reference

29 March 2018

1 reference

1 reference

1

1 reference

29 March 2018

author name string

Wray N

2

1 reference

29 March 2018

Brody B

3

1 reference

29 March 2018

Ashton C

4

1 reference

29 March 2018

Giesler B

5

1 reference

29 March 2018

Watkins H

6

1 reference

29 March 2018

language of work or name

English

0 references

publication date

1 October 1997

1 reference

29 March 2018

Social Science and Medicine

published in

1 reference

29 March 2018

volume

45

1 reference

29 March 2018

issue

8

1 reference

29 March 2018

page(s)

1299-1309

1 reference

29 March 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

Patients' choice of treatment in stage D prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

A brief POMS measure of distress for cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

Medical or surgical orchidectomy: the patients' choice

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

Quality of life in patients with prostatic cancer. A feasibility study. The Members of Quality of Life Committee of the EORTC Genitourinary Group

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

Development of a measure to assess the perceived illness experience after treatment for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

Quality of life in patients with muscle-infiltrating bladder cancer and hormone-resistant prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

Prostate cancer: screening, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

Body awareness and medical care utilization among older adults in an HMO

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

Evaluating the efficacy of medical treatment: possibilities and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

Stigma in patients with rectal cancer: a community study

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

Quality of life end points in cancer clinical trials: review and recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

Symptom prevalence, characteristics and distress in a cancer population.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

Buserelin as primary therapy in advanced prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

Buserelin treatment of advanced prostatic carcinoma. Long-term follow-up of antitumor responses and improved quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2897%2900058-0

7 January 2021

10.1016/S0277-9536(97)00058-0

Identifiers

DOI

1 reference

29 March 2018

1 reference

29 March 2018